GenScript

GenScript believes that CustomArray's oligonucleotide synthesis and microarray manufacturing technology will enable it to better serve its customers.

The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.

NEW YORK (GenomeWeb News) – Roche said this week that it will invest CHF 240 million ($258.4 million) in a new diagnostics center at its Penzberg, Germany biotech center near Munich.

NEW YORK (GenomeWeb News) – Almac Diagnostics said this week that it has launched a next-generation sequencing service to its portfolio, which also includes microarray, qPCR, and immunohistochemical offerings.

Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.

The firms intend to develop next-generation proteins and enzymes based on synthetic biology.

New Products

Premium

Shimadzu, HealthLinx, Protein Discovery, GenScript

New Products

Premium

Genscript, Covance

A proposed HHS guidance for synthetic biology roughly fits a harmonization effort started by the International Gene Synthesis Consortium.

Five firms have formed the International Gene Synthesis Consortium to set gene and customer screening protocols that address security concerns.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.